Cargando…

The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study

BACKGROUND AND OBJECTIVES: Gastric cancer is known as one of the most common cancers and causes of deaths. Early and proper diagnosis is one of the most important things for treatment response. Therefore, this study aimed to determine the expression of p53, CD44, Ki-67, and HER-2/neu markers in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahadi, Mahsa, Moradi, Afshin, Musavinejad, Leila, Movafagh, Abolfazl, Moradi, Arsham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568877/ https://www.ncbi.nlm.nih.gov/pubmed/32592354 http://dx.doi.org/10.31557/APJCP.2020.21.6.1607

Ejemplares similares

Status of HER-2/neu receptors and Ki-67 in breast cancer of Indian women
por: Singhai, Rajeev, et al.
Publicado: (2011)

Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma
por: Ahmed, Ayesha, et al.
Publicado: (2018)

Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran
por: Sanaat, Zohreh, et al.
Publicado: (2013)

Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals
por: Kishanifarahani, Zeinab, et al.
Publicado: (2019)

Evaluation of the Standardization in Semen Analysis Performance According to the WHO Protocols Among Laboratories in Tehran, Iran
por: Ahadi, Masha, et al.
Publicado: (2019)

Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
por: Puri, Vandana, et al.
Publicado: (2011)

Clinicopathologic Features of Colorectal Polyps in Shahid Beheshti University of Medical Sciences (SBMU)
por: Ahadi, Mahsa, et al.
Publicado: (2019)

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
por: Rakovitch, E, et al.
Publicado: (2012)

Immunohistochemical Profiling of HER-2/neu, Steroid Hormone Receptors and KI-67 Biomarkers in A Cohort of Nigerian Women with Breast Cancer
por: Ayandipo, Omobolaji O., et al.
Publicado: (2023)

Coexistence of HER2, Ki67, and p53 in Osteosarcoma: A Strong Prognostic Factor
por: Mardanpour, Keykhosro, et al.
Publicado: (2016)

An Investigation on the Results of Cytopathologic Tests of Pancreatobiliary System Performed in the Pathology Department in Iran
por: Moradi, Afshin, et al.
Publicado: (2021)

Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study
por: Shokouh, Taghipour Zahir, et al.
Publicado: (2015)

Expression of P53 Protein and Ki-67 Antigen in Oral Leukoplakia with Different Histopathological Grades of Epithelial Dysplasia
por: Suwasini, S., et al.
Publicado: (2018)

Her2/neu Expression in Wilms' Tumor and Correlation With Histopathologic Findings
por: Babashahi, Mashaallah, et al.
Publicado: (2013)

A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
por: Kar, Ketaki, et al.
Publicado: (2021)

A study of histopathological spectrum and expression of Ki-67, TP53 in primary brain tumors of pediatric age group
por: Sengupta, Subhalakshmi, et al.
Publicado: (2012)

The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-π as clinico-histopathological markers for colorectal cancer()
por: He, Zhenyu, et al.
Publicado: (2010)

Ki-67, p53 and BCL-2 Expressions and their Association with Clinical Histopathology of Breast Cancer among Women in Tanzania
por: Mansouri, Hidaya, et al.
Publicado: (2019)

Evaluation of P53 and CK20 Immunohistochemical Markers in Comparison with Morphologic Findings in Low- and High-grade Urothelial Carcinomas
por: Ahadi, Mahsa, et al.
Publicado: (2021)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Evaluation of GATA3 and GCDFP15 Expression in Triple Negative Breast Cancers
por: Ahadi, Mahsa, et al.
Publicado: (2023)

The impact of immunohistochemical markers of Ki-67 and p53 on the long-term outcome of growth hormone-secreting pituitary adenomas: A cohort study
por: Alimohamadi, Maysam, et al.
Publicado: (2014)

Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
por: ALCO, GUL, et al.
Publicado: (2015)

Histopathological Spectrum of Meningiomas with Emphasis on Prognostic Role of Ki67 Labelling Index
por: Solanke, Girish, et al.
Publicado: (2020)

Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2/neu, p53, and Ki67 in oral squamous cell carcinoma
por: Mohanapure, Neelam Sureshrao, et al.
Publicado: (2022)

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
por: Peng, Jian-Heng, et al.
Publicado: (2019)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Evaluation of P57, P53 and Ki67 Expression in Meningiomas
por: Küçükosmanoğlu, İlknur, et al.
Publicado: (2022)

Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
por: Shaabanpour Aghamaleki, Fateme, et al.
Publicado: (2019)

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
por: Brodowicz, T, et al.
Publicado: (2001)

Gastrointestinal Stromal Tumor and Ki-67 as a Prognostic Indicator
por: Kadado, Kevin J, et al.
Publicado: (2022)

Ki-67 immunostaining in astrocytomas: Association with histopathological grade – A South Indian study
por: Shivaprasad, Nandish Vastrad, et al.
Publicado: (2016)

Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population
por: Theresia, Emilia, et al.
Publicado: (2020)

Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum
Publicado: (2022)

Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67
por: Asgari, Mojgan, et al.
Publicado: (2016)

Immunohistochemical expression of p53, Ki67, α-SMA, CD44 and CD31 in different histological subtypes of basal cell carcinoma
por: Cojocaru, Anca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pgbuq7apafp8dueo19bhq5fqra